XML 43 R33.htm IDEA: XBRL DOCUMENT v3.22.2
Stockholders' Equity (Tables)
 6 Months Ended
Jun. 30, 2022
Stockholders' Equity Note [Abstract]  
Schedule of preferred stock dividend declaration and payment
The following table presents cash dividends declared by the Company on its Series B Preferred Stock from January 1, 2022 through June 30, 2022:

Declaration Date Record DatePayment DateDividend Per Share
May 18, 2022June 1, 2022June 30, 2022$0.46875
February 17, 2022March 1, 2022March 31, 2022$0.46875
The following table presents cash dividends declared by the Company on its Series C Preferred Stock from January 1, 2022 through June 30, 2022:

Declaration Date Record DatePayment DateDividend Per Share
May 18, 2022June 1, 2022June 30, 2022$0.40625
February 17, 2022March 1, 2022March 31, 2022$0.40625
Schedule of common stock dividend declaration and payment
The following table presents cash dividends declared by the Company on its common stock from January 1, 2022 through June 30, 2022:

Declaration Date
Record DatePayment DateDividend Per Share 
June 15, 2022June 30, 2022July 29, 2022$0.440(1)
March 11, 2022March 22, 2022April 29, 2022$0.440
(1) At June 30, 2022, the Company had accrued dividends and dividend equivalents payable of $45.0 million related to the common stock dividend declared on June 15, 2022. The $0.44 per share dividend declared on March 11, 2022, has been adjusted to reflect the Company’s 1-for-4 reverse stock split effected on April 4, 2022; the amount actually paid in respect of such dividend was $0.11 per share, which was based on the pre-split number of shares held by stockholders at the record date for such dividend (March 22, 2022).
Schedule of changes in balances of each component of the entity's AOCI
The following table presents changes in the balances of each component of the Company’s AOCI for the three and six months ended June 30, 2022:
Three Months Ended
June 30, 2022		Six Months Ended
June 30, 2022
(In Thousands)Net Unrealized
Gain/(Loss) on
AFS Securities		Net 
Gain/(Loss)
on Swaps
Net Unrealized Gain/(Loss) on Financing Agreements (1)
Total 
AOCI		Net Unrealized
Gain/(Loss) on
AFS Securities		Net 
Gain/(Loss)
on Swaps
Net Unrealized Gain/(Loss) on Financing Agreements (1)
Total 
AOCI
Balance at beginning of period$41,856 $— $— $41,856 $46,833 $— $(1,255)$45,578 
OCI before reclassifications(4,937)— — (4,937)(9,914)— 1,255 (8,659)
Amounts reclassified from AOCI— — — — — — — — 
Net OCI during the period (2)
(4,937)— — (4,937)(9,914)— 1,255 (8,659)
Balance at end of period$36,919 $— $— $36,919 $36,919 $— $— $36,919 

(1)Net Unrealized Gain/(Loss) on Financing Agreements at Fair Value due to changes in instrument-specific credit risk.
(2) For further information regarding changes in OCI, see the Company’s consolidated statements of comprehensive income/(loss).
 

The following table presents changes in the balances of each component of the Company’s AOCI for the three and six months ended June 30, 2021:
Three Months Ended
June 30, 2021		Six Months Ended
June 30, 2021
(In Thousands)Net Unrealized
Gain/(Loss) on
AFS Securities		Net Gain/(Loss) on Swaps
Net Unrealized Gain/(Loss) on Financing Agreements (1)
Total
AOCI		Net Unrealized
Gain/(Loss) on
AFS Securities		Net 
Gain/(Loss) on Swaps
Net Unrealized Gain/(Loss) on Financing Agreements (1)
Total
AOCI
Balance at beginning of period$75,752 $— $(2,079)$73,673 $79,607 $— $(2,314)$77,293 
OCI before reclassifications(9,589)— 491 (9,098)(13,444)— 726 (12,718)
Amounts reclassified from AOCI— — — — — — — — 
Net OCI during the period (2)
(9,589)— 491 (9,098)(13,444)— 726 (12,718)
Balance at end of period$66,163 $— $(1,588)$64,575 $66,163 $— $(1,588)$64,575 

(1)  Net Unrealized Gain/(Loss) on Financing Agreements at Fair Value due to changes in instrument-specific credit risk.
(2)  For further information regarding changes in OCI, see the Company’s consolidated statements of comprehensive income/(loss).